Erosive oral lichen planus after pegylated-interferon therapy for chronic hepatitis B
- PMID: 29687070
- PMCID: PMC5909481
- DOI: 10.1016/j.jdcr.2017.09.034
Erosive oral lichen planus after pegylated-interferon therapy for chronic hepatitis B
Keywords: IFN-α; IFN-α, interferon α; LP, lichen planus; hepatitis B; interferon; oral lichen planus.
Figures
References
-
- Friedrich R.E., Heiland M., El-Moawen A., Dogan A., von Schrenck T., Loning T. Oral lichen planus in patients with chronic liver diseases. Infection. 2003;31(6):383–386. - PubMed
-
- Maticic M., Poljak M., Lunder T., Rener-Sitar K., Stojanovic L. Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area. J Eur Acad Dermatol Venereol. 2008;22(7):779–788. - PubMed
-
- Remmerbach T.W., Liese J., Krause S. No association of oral lichen planus and hepatitis C virus infection in central Germany. Clin Oral Investig. 2016;20(1):193–197. - PubMed
-
- Dalekos G.N., Christodoulou D., Kistis K.G., Zervou E.K., Hatzis J., Tsianos E.V. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis. Eur J Gastroenterol Hepatol. 1998;10(11):933–939. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources